Report cover image

Global Donepezil Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 197 Pages
SKU # APRC20280588

Description

Summary

According to APO Research, the global Donepezil market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Donepezil is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Donepezil is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Donepezil market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Donepezil is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Donepezil market include Apotex, ARK PHA.LTD, Cipla, Dr Reddy's Laboratories, Hansoh Pharma, Jishengtang Pharma, Luoxin, Sun Pharmaceutical and Pfizer, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Donepezil, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Donepezil, also provides the sales of main regions and countries. Of the upcoming market potential for Donepezil, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Donepezil sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Donepezil market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Donepezil sales, projected growth trends, production technology, application and end-user industry.

Donepezil Segment by Company

Apotex
ARK PHA.LTD
Cipla
Dr Reddy's Laboratories
Hansoh Pharma
Jishengtang Pharma
Luoxin
Sun Pharmaceutical
Pfizer
Sandoz
Teva
Eisai
Donepezil Segment by Type

5mg
10mg
23mg
Donepezil Segment by Application

Hospitals
Clinics
Drugstore
Donepezil Segment by Region

North America

United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Donepezil status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Donepezil market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Donepezil significant trends, drivers, influence factors in global and regions.
6. To analyze Donepezil competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Donepezil and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Donepezil market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Donepezil industry.
Chapter 3: Detailed analysis of Donepezil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Donepezil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Donepezil in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

197 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Donepezil Sales Value (2020-2031)
1.2.2 Global Donepezil Sales Volume (2020-2031)
1.2.3 Global Donepezil Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Donepezil Market Dynamics
2.1 Donepezil Industry Trends
2.2 Donepezil Industry Drivers
2.3 Donepezil Industry Opportunities and Challenges
2.4 Donepezil Industry Restraints
3 Donepezil Market by Company
3.1 Global Donepezil Company Revenue Ranking in 2024
3.2 Global Donepezil Revenue by Company (2020-2025)
3.3 Global Donepezil Sales Volume by Company (2020-2025)
3.4 Global Donepezil Average Price by Company (2020-2025)
3.5 Global Donepezil Company Ranking (2023-2025)
3.6 Global Donepezil Company Manufacturing Base and Headquarters
3.7 Global Donepezil Company Product Type and Application
3.8 Global Donepezil Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Donepezil Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Donepezil Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Donepezil Market by Type
4.1 Donepezil Type Introduction
4.1.1 5mg
4.1.2 10mg
4.1.3 23mg
4.2 Global Donepezil Sales Volume by Type
4.2.1 Global Donepezil Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Donepezil Sales Volume by Type (2020-2031)
4.2.3 Global Donepezil Sales Volume Share by Type (2020-2031)
4.3 Global Donepezil Sales Value by Type
4.3.1 Global Donepezil Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Donepezil Sales Value by Type (2020-2031)
4.3.3 Global Donepezil Sales Value Share by Type (2020-2031)
5 Donepezil Market by Application
5.1 Donepezil Application Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.1.3 Drugstore
5.2 Global Donepezil Sales Volume by Application
5.2.1 Global Donepezil Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Donepezil Sales Volume by Application (2020-2031)
5.2.3 Global Donepezil Sales Volume Share by Application (2020-2031)
5.3 Global Donepezil Sales Value by Application
5.3.1 Global Donepezil Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Donepezil Sales Value by Application (2020-2031)
5.3.3 Global Donepezil Sales Value Share by Application (2020-2031)
6 Donepezil Regional Sales and Value Analysis
6.1 Global Donepezil Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Donepezil Sales by Region (2020-2031)
6.2.1 Global Donepezil Sales by Region: 2020-2025
6.2.2 Global Donepezil Sales by Region (2026-2031)
6.3 Global Donepezil Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Donepezil Sales Value by Region (2020-2031)
6.4.1 Global Donepezil Sales Value by Region: 2020-2025
6.4.2 Global Donepezil Sales Value by Region (2026-2031)
6.5 Global Donepezil Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Donepezil Sales Value (2020-2031)
6.6.2 North America Donepezil Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Donepezil Sales Value (2020-2031)
6.7.2 Europe Donepezil Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Donepezil Sales Value (2020-2031)
6.8.2 Asia-Pacific Donepezil Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Donepezil Sales Value (2020-2031)
6.9.2 South America Donepezil Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Donepezil Sales Value (2020-2031)
6.10.2 Middle East & Africa Donepezil Sales Value Share by Country, 2024 VS 2031
7 Donepezil Country-level Sales and Value Analysis
7.1 Global Donepezil Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Donepezil Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Donepezil Sales by Country (2020-2031)
7.3.1 Global Donepezil Sales by Country (2020-2025)
7.3.2 Global Donepezil Sales by Country (2026-2031)
7.4 Global Donepezil Sales Value by Country (2020-2031)
7.4.1 Global Donepezil Sales Value by Country (2020-2025)
7.4.2 Global Donepezil Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Donepezil Sales Value Growth Rate (2020-2031)
7.5.2 USA Donepezil Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Donepezil Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Donepezil Sales Value Growth Rate (2020-2031)
7.6.2 Canada Donepezil Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Donepezil Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Donepezil Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Donepezil Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Donepezil Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Donepezil Sales Value Growth Rate (2020-2031)
7.8.2 Germany Donepezil Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Donepezil Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Donepezil Sales Value Growth Rate (2020-2031)
7.9.2 France Donepezil Sales Value Share by Type, 2024 VS 2031
7.9.3 France Donepezil Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Donepezil Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Donepezil Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Donepezil Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Donepezil Sales Value Growth Rate (2020-2031)
7.11.2 Italy Donepezil Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Donepezil Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Donepezil Sales Value Growth Rate (2020-2031)
7.12.2 Spain Donepezil Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Donepezil Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Donepezil Sales Value Growth Rate (2020-2031)
7.13.2 Russia Donepezil Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Donepezil Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Donepezil Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Donepezil Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Donepezil Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Donepezil Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Donepezil Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Donepezil Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Donepezil Sales Value Growth Rate (2020-2031)
7.16.2 China Donepezil Sales Value Share by Type, 2024 VS 2031
7.16.3 China Donepezil Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Donepezil Sales Value Growth Rate (2020-2031)
7.17.2 Japan Donepezil Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Donepezil Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Donepezil Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Donepezil Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Donepezil Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Donepezil Sales Value Growth Rate (2020-2031)
7.19.2 India Donepezil Sales Value Share by Type, 2024 VS 2031
7.19.3 India Donepezil Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Donepezil Sales Value Growth Rate (2020-2031)
7.20.2 Australia Donepezil Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Donepezil Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Donepezil Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Donepezil Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Donepezil Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Donepezil Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Donepezil Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Donepezil Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Donepezil Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Donepezil Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Donepezil Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Donepezil Sales Value Growth Rate (2020-2031)
7.24.2 Chile Donepezil Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Donepezil Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Donepezil Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Donepezil Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Donepezil Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Donepezil Sales Value Growth Rate (2020-2031)
7.26.2 Peru Donepezil Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Donepezil Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Donepezil Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Donepezil Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Donepezil Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Donepezil Sales Value Growth Rate (2020-2031)
7.28.2 Israel Donepezil Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Donepezil Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Donepezil Sales Value Growth Rate (2020-2031)
7.29.2 UAE Donepezil Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Donepezil Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Donepezil Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Donepezil Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Donepezil Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Donepezil Sales Value Growth Rate (2020-2031)
7.31.2 Iran Donepezil Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Donepezil Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Donepezil Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Donepezil Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Donepezil Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Apotex
8.1.1 Apotex Comapny Information
8.1.2 Apotex Business Overview
8.1.3 Apotex Donepezil Sales, Value and Gross Margin (2020-2025)
8.1.4 Apotex Donepezil Product Portfolio
8.1.5 Apotex Recent Developments
8.2 ARK PHA.LTD
8.2.1 ARK PHA.LTD Comapny Information
8.2.2 ARK PHA.LTD Business Overview
8.2.3 ARK PHA.LTD Donepezil Sales, Value and Gross Margin (2020-2025)
8.2.4 ARK PHA.LTD Donepezil Product Portfolio
8.2.5 ARK PHA.LTD Recent Developments
8.3 Cipla
8.3.1 Cipla Comapny Information
8.3.2 Cipla Business Overview
8.3.3 Cipla Donepezil Sales, Value and Gross Margin (2020-2025)
8.3.4 Cipla Donepezil Product Portfolio
8.3.5 Cipla Recent Developments
8.4 Dr Reddy's Laboratories
8.4.1 Dr Reddy's Laboratories Comapny Information
8.4.2 Dr Reddy's Laboratories Business Overview
8.4.3 Dr Reddy's Laboratories Donepezil Sales, Value and Gross Margin (2020-2025)
8.4.4 Dr Reddy's Laboratories Donepezil Product Portfolio
8.4.5 Dr Reddy's Laboratories Recent Developments
8.5 Hansoh Pharma
8.5.1 Hansoh Pharma Comapny Information
8.5.2 Hansoh Pharma Business Overview
8.5.3 Hansoh Pharma Donepezil Sales, Value and Gross Margin (2020-2025)
8.5.4 Hansoh Pharma Donepezil Product Portfolio
8.5.5 Hansoh Pharma Recent Developments
8.6 Jishengtang Pharma
8.6.1 Jishengtang Pharma Comapny Information
8.6.2 Jishengtang Pharma Business Overview
8.6.3 Jishengtang Pharma Donepezil Sales, Value and Gross Margin (2020-2025)
8.6.4 Jishengtang Pharma Donepezil Product Portfolio
8.6.5 Jishengtang Pharma Recent Developments
8.7 Luoxin
8.7.1 Luoxin Comapny Information
8.7.2 Luoxin Business Overview
8.7.3 Luoxin Donepezil Sales, Value and Gross Margin (2020-2025)
8.7.4 Luoxin Donepezil Product Portfolio
8.7.5 Luoxin Recent Developments
8.8 Sun Pharmaceutical
8.8.1 Sun Pharmaceutical Comapny Information
8.8.2 Sun Pharmaceutical Business Overview
8.8.3 Sun Pharmaceutical Donepezil Sales, Value and Gross Margin (2020-2025)
8.8.4 Sun Pharmaceutical Donepezil Product Portfolio
8.8.5 Sun Pharmaceutical Recent Developments
8.9 Pfizer
8.9.1 Pfizer Comapny Information
8.9.2 Pfizer Business Overview
8.9.3 Pfizer Donepezil Sales, Value and Gross Margin (2020-2025)
8.9.4 Pfizer Donepezil Product Portfolio
8.9.5 Pfizer Recent Developments
8.10 Sandoz
8.10.1 Sandoz Comapny Information
8.10.2 Sandoz Business Overview
8.10.3 Sandoz Donepezil Sales, Value and Gross Margin (2020-2025)
8.10.4 Sandoz Donepezil Product Portfolio
8.10.5 Sandoz Recent Developments
8.11 Teva
8.11.1 Teva Comapny Information
8.11.2 Teva Business Overview
8.11.3 Teva Donepezil Sales, Value and Gross Margin (2020-2025)
8.11.4 Teva Donepezil Product Portfolio
8.11.5 Teva Recent Developments
8.12 Eisai
8.12.1 Eisai Comapny Information
8.12.2 Eisai Business Overview
8.12.3 Eisai Donepezil Sales, Value and Gross Margin (2020-2025)
8.12.4 Eisai Donepezil Product Portfolio
8.12.5 Eisai Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Donepezil Value Chain Analysis
9.1.1 Donepezil Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Donepezil Sales Mode & Process
9.2 Donepezil Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Donepezil Distributors
9.2.3 Donepezil Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.